BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38007812)

  • 1. [Focal congenital hyperinsulinism].
    Tallós Z; Luczay A; Balogh L; Méder Ü; Várkonyi I; Seszták T; Borka K; Harsányi L; Kálmán A
    Orv Hetil; 2023 Nov; 164(47):1877-1884. PubMed ID: 38007812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital hyperinsulinism: localization of a focal lesion with
    States LJ; Becker SA; De León DD
    Pediatr Radiol; 2022 Apr; 52(4):693-701. PubMed ID: 34668049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congenital hyperinsulinism : contributions of chemistry, therapeutic response, genetics and imaging].
    Vandendaele C; Kaschten S; Parent AS; Fudvoye J
    Rev Med Liege; 2024 Mar; 79(3):168-174. PubMed ID: 38487911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital hyperinsulinism treated by surgical resection of the hyperplastic lesion which had been preoperatively diagnosed by 18F-DOPA PET examination in Japan: a nationwide survey.
    Kanamori Y; Watanabe T; Yorifuji T; Masue M; Sasaki H; Nio M
    Pediatr Surg Int; 2018 Oct; 34(10):1093-1098. PubMed ID: 30076450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
    Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
    Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterogeneity of focal forms of congenital hyperinsulinism.
    Ismail D; Kapoor RR; Smith VV; Ashworth M; Blankenstein O; Pierro A; Flanagan SE; Ellard S; Hussain K
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E94-9. PubMed ID: 22031516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A compound heterozygous mutation of ABCC8 gene causing a diazoxide-unresponsive congenital hyperinsulinism with an atypical form: Not a focal lesion in the pancreas reported by ¹⁸F-DOPA-PET/CT scan.
    Zhang W; Liu L; Wen Z; Cheng J; Li C; Li X; Niu H; Wang F; Sheng H; Liu H
    Gene; 2015 Nov; 572(2):222-6. PubMed ID: 26162674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F-fluoro-L-DOPA PET-CT imaging combined with genetic analysis for optimal classification and treatment in a child with severe congenital hyperinsulinism].
    Arbizu Lostao J; Fernández-Marmiesse A; Garrastachu Zumarrán P; Martino Casado E; Azcona San Julián C; Carracedo A; Richter Echevarría JA
    An Pediatr (Barc); 2008 May; 68(5):481-5. PubMed ID: 18447993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital Hyperinsulinism Caused by Mutations in
    Butnariu LI; Bizim DA; Păduraru G; Păduraru L; Moisă ȘM; Popa S; Gimiga N; Ghiga G; Bădescu MC; Lupu A; Vasiliu I; Trandafir LM
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
    Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a diffuse form of hyperinsulinemic hypoglycemia by 18-fluoro-L-3,4 dihydroxyphenylalanine positron emission tomography/CT in a patient carrying a novel mutation of the HADH gene.
    Di Candia S; Gessi A; Pepe G; Sogno Valin P; Mangano E; Chiumello G; Gianolli L; Proverbio MC; Mora S
    Eur J Endocrinol; 2009 Jun; 160(6):1019-23. PubMed ID: 19318379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid genetic analysis, imaging with 18F-DOPA-PET/CT scan and laparoscopic surgery in congenital hyperinsulinism.
    Cherubini V; Bagalini LS; Ianilli A; Marigliano M; Biagioni M; Carnielli V; Iasonni V; Berbellini A; Hussain K; Gabrielli O
    J Pediatr Endocrinol Metab; 2010; 23(1-2):171-7. PubMed ID: 20432820
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    States LJ; Davis JC; Hamel SM; Becker SA; Zhuang H
    J Nucl Med; 2021 Jul; 62(Suppl 2):51S-56S. PubMed ID: 34230074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital hyperinsulinism: current trends in diagnosis and therapy.
    Arnoux JB; Verkarre V; Saint-Martin C; Montravers F; Brassier A; Valayannopoulos V; Brunelle F; Fournet JC; Robert JJ; Aigrain Y; Bellanné-Chantelot C; de Lonlay P
    Orphanet J Rare Dis; 2011 Oct; 6():63. PubMed ID: 21967988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
    J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
    de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
    J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Feasibility of domestic (18)F-DOPA PET/CT scanning in the differential diagnosis of pancreatic lesions in children with hyperinsulinemic hypoglycemia].
    Zhang MY; Ge JJ; Pei Z; Dong KR; Chen L; Wang X; Zhang ZW; Li XJ; Xi L; Cheng RQ; Lu GP; Guan YH; Luo FH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):785-789. PubMed ID: 29050119
    [No Abstract]   [Full Text] [Related]  

  • 19. Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism.
    Yorifuji T; Hosokawa Y; Fujimaru R; Kawakita R; Doi H; Matsumoto T; Nishibori H; Masue M
    Horm Res Paediatr; 2011; 76(4):286-90. PubMed ID: 21912073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.